Education

Timely Topics in Transplantation

Timely Topics in Transplantation webinars are the perfect opportunity to listen to a live presentation on a current issue and ask questions directly to the presenter. All webinars are available on demand after the live air date. 

How to Register for an Individual Webinar
Pre-registration is required for each webinar in order to receive reminders and access instructions on the day of the webinar. Click "Register" under any webinar below and you will be taken to the AST digital library website. On that website, click the "Register" link to add the webinar to your cart and proceed to checkout.

AST MEMBERS: To remove the $25 fee, simply log in with your AST username and password and the charge will change to $0.
NON-MEMBERS: If you have an account on the AST website, sign in with those credentials. If you do not have an account with AST, create an account and proceed with the purchase (your account will not be an AST website account nor a membership account; it is your webinar access account).

Epigenetic Modifications of Immune Cells and their Importance for Alloimmunity

Wednesday, September 12, 2018 - 2:00 pm to 3:00 pm EDT

Register

Speaker: Andrew Wells, PhD • University of Pennsylvania and CHOP
Moderator: Jonathan Maltzman, MD, PhD • Stanford University

Barriers to Achieving Immune Tolerance through Hematopoietic Mixed Chimerism in Deceased Donation

Thursday, September 20, 2018 - 2:00 pm to 3:00 pm EDT

Register

Speaker: David H. Sachs, MD • CUMC & MGH/HMS
Moderator: Sebastian Eriksson Giwa, PhD • Ossium Health and Sylvatica Biotech

After participating in this webinar, the learner will be able to:

  1. Evaluate the protocols in clinical trials for inducing immune tolerance.
  2. Identify current limitations to immune tolerance protocols.
  3. Identify potential solutions through the use of organ and cell preservation technologies.

Family Planning in SOT

Wednesday, October 10, 2018 - 2:00 pm to 3:00 pm EDT

Register

Speaker: Lisa Coscia, RN, BSN, CCTC • Transplant Pregnancy Registry International
Moderator: Monika Sarkar, MD, MAS • University of California, San Francisco

Significance, Identification, and Treatment of Post-Thoracic Transplant Circulating Antibodies

Wednesday, October 31, 2018 - 2:00 pm to 3:00 pm EDT

Register

Speakers:
Ramsey Hachem, MD • Washington University School of Medicine
Deborah Jo Levine, MD • University of Texas Health Science Center

Moderator: Sangeeta Bhorade, MD • Northwestern University

Transplant Metrics - Should We Enforce or Rewrite the Final Rule?

Wednesday, November 14, 2018 - 2:00 pm to 3:00 pm EST

Register

Speaker: Jesse Schold, PhD, M.Stat, M.Ed • Cleveland Clinic
Moderator: Anil Chandraker, MD, FAST, FRCP • Brigham and Women's Hospital

Psychosocial Aspects of Transition of the Newly Adult, New Patient

Wednesday, November 28, 2018 - 2:00 pm to 3:00 pm EST

Register

Speaker: Beverly Kosmach-Park, DNP, RN, FAAN • Children's Hospital of Pittsburgh
Moderator: Sandra Amaral, MD, MHS • Children's Hospital of Philadelphia

Building Blocks of a Transplant QAPI Plan

Wednesday, December 12, 2018 - 2:00 pm to 3:00 pm EST

Register

Speaker: Linda Ohler, MSN, RN, CCTC, FAAN, FAST • New York University Langone Transplant Institute
Moderator: Marian O'Rourke, RN, BSN, CCTC • Jackson Memorial Hospital

Optimizing Informed Consent to Inform Donors and Recipients about Possible Psychological and Financial Risks

Wednesday, January 16, 2019 - 2:00 pm to 3:00 pm EST

Register

Speaker: Rebecca Hays, MSW, APSW • University of Wisconsin Hospital and Clinics
Moderator: Jim Rodrigue, PhD • Beth Israel Deaconess Medical Center

Which Live Donor Kidney is Better?

Wednesday, February 20, 2019 - 2:00 pm to 3:00 pm EST

Register

Speakers:
Peter Reese, MD, MSCE • University of Pennsylvania School of Medicine
John Gill, MD, MS, FAST • University of British Columbia


Moderator: Didier Mandelbrot, MD • UWHealth

 

Case-Based Multidisciplinary Approach to Cardiac and Pulmonary Vascular Disease Risk Assessment in Liver Transplantation

Wednesday, March 20, 2019 - 2:00 pm to 3:00 pm EDT

Register

Speakers:
Lisa VanWagner, MD, MSc • Northwestern Medicine
Marina Serper, MD, MS • University of Pennsylvania
Christopher Darling, DO • University of Wisconsin

Moderator: Shelley Hall, MD • Baylor University Medical Center - Dallas

After participating in this webinar, the learner will be able to:

  1. Construct an evidence-based plan for the assessment of cardiovascular risk in the liver transplant candidate.
  2. Explain the diagnostic criteria for portopulmonary hypertension, treatment strategies to improve liver transplant candidacy and intraoperative management considerations.
  3. Discuss management approaches for the leading perioperative cardiovascular complications (e.g., atrial fibrillation, congestive heart failure and stroke) in liver transplant recipients.

Pages

Archived Webinars

Respiratory Viral Infections in Lung Transplantation

Thursday, June 21, 2018 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Cynthia Fisher, MD, MPH • University of Washington
Moderator: Sangeeta Bhorade, MD • Northwestern University

After participating in this webinar, the learner will be able to:

  1. Describe the incidence and clinical impact of respiratory viruses (RVs) in lung transplant recipients (LTR).
  2. Explain the evidence linking RVI to chronic lung allograft dysfunction (CLAD).
  3. List currently available and promising investigational therapies for: RSV, Influenza, and PIV.
  4. Discuss prevention strategies.

Change Management

Wednesday, March 21, 2018 - 2:00 pm to 3:00 pm EDT

View Archive

View additional resources

Speaker: Gwen McNatt, PhD, MS, CNN • Northwestern Memorial Hospital
Moderator: Marian O'Rourke, RN, CCTC • Jackson Memorial Hospital

After participating in this webinar, the learner will be able to:

  1. Describe at least two change models and how to apply them.
  2. Discuss change readiness and how to assess readiness.
  3. Discuss the change curve during implementation of a change.
  4. Describe strategies to sustain change.

Update in Vaccinations (Included in Both Pediatric and ID Educational Gaps)

Wednesday, February 21, 2018 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center
Moderator: Deepali Kumar, MD  • University Health Network

After participating in this webinar, the learner will be able to:

  1. Describe the currently recommended evaluation and administration of vaccination in the solid organ transplant candidate.
  2. Discuss considerations for vaccination in solid organ transplant recipients including timing and responses.
  3. Recognize the considerations for live-viral vaccination before and after solid organ transplantation, including newly available vaccinations.

Optimizing Viral Diagnostics in Organ Transplantation: The Long and Winding Road

Wednesday, February 7, 2018 - 2:00 pm to 3:00 pm EST

View Archive

Speakers:
Hans H. Hirsch, MD, MSc • University of Basel
Oriol Bestard, MD, PhD • Bellvitge University Hospital, IDIBELL
Olivia M. Martinez, PhD • Stanford University School of Medicine

Moderator:
Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center

After participating in this webinar, the learner will be able to:

  1. Describe the limitations of current viral assays to diagnose CMV, EBV, and BK polyomavirus.
  2. Discuss the emerging diagnostic testing including host responses for CMV and BK polyoma virus.
  3. Describe the emerging concepts of the immune response to EBV that permit transition from infection to Post-Transplant Lymphoproliferative Disease.

Improving Rigor and Reproducibility in Animal Models

Thursday, January 18, 2018 - 2:00 pm to 3:00 pm EST

View Archive

Read the Q&A not answered during the webinar

Speaker: Ronald Gill, PhD • University of Colorado - Denver
Moderator: Leonardo Riella, MD, PhD, FASN, FAST • Brigham and Women's Hospital

After participating in this webinar, the learner will be able to:

  1. Describe current concerns in biomedical research about the reliability of pre-clinical studies using small animal models.
  2. Convey the potential impact of publication bias in pre-clinical research.
  3. Illustrate the use of multi-center pre-clinical studies.
  4. Suggest guidelines about conducting pre-clinical research.

Invasive Fungal Diseases – Emerging Diagnostics and New Therapies

Tuesday, December 5, 2017 - 2:00 pm to 3:00 pm EST

View Archive

Read the Q&A not answered during webinar

Speaker: Francisco Marty, MD • Brigham and Women's Hospital
Moderator: Leonardo Riella, MD, PhD, FASN, FAST • Brigham and Women's Hospital

After participating in this webinar, the learner will be able to:

  1. Describe the most common invasive fungal infections post-transplantation.
  2. Define the available diagnostic tests and upcoming assays for fungal infection.
  3. Summarize the new anti-fungal therapies and side effects.

Novel Immunosuppressants: Applicability to Thoracic Organ Transplantation?

Tuesday, November 14, 2017 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Jon Kobashigawa, MD • Cedars Sinai Heart Institute
Moderator: Sean Pinney, MD • Mount Sinai School of Medicine

After participating in this webinar, the learner will be able to: 

  1. Relate the advances in immunosuppression therapy.
  2. Describe the mechanisms of immunosuppression.
  3. Identify the newer immunosuppression agents and future therapies.

Management of the Failing Kidney Allograft

Tuesday, October 17, 2017 - 2:00 pm to 3:00 pm EDT

View Archive

Read the Q&A not answered during webinar

Speaker: Martha Pavlakis, MD • Beth Israel Deaconess Medical Center
Moderator: Tarek Alhamad, MD • Washington University School of Medicine in St. Louis

After participating in this webinar, the learner will be able to:

  1. Identify the challenges in managing the kidney transplant patient with a failing allograft.
  2. Describe the increased risks of death and sepsis for the allograft recipient as they return to dialysis.
  3. Discuss the options for managing immunosuppression and end stage rejection in the failed allograft.

Epitope Matching in Kidney Allocation

Wednesday, September 27, 2017 - 2:00 pm to 3:00 pm EDT

View Archive

Polling questions and answers are available for download here.

Speaker: Massimo Mangiola, PhD • University of Pittsburgh Medical Center
Moderator: Julie Yabu, MD • UCLA

After participating in this webinar, the learner will be able to:

  1. Describe epitopes in the context of transplantation.
  2. Discuss the importance of epitopes in HLA compatiblity and optimizing graft outcome.
  3. Summarize how to potentially use "epitope tools" in HLA antibody analysis and matching of donors and recipients pairs.

Precision Medicine Approaches in Transplantation

Monday, December 12, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Minnie Sarwal, MD, PhD, MRCP, DCH, FRCP • University of California San Francisco
Moderator: Julie Yabu, MD • Stanford University
 

After participating in this webinar, the learner will be able to:

  1. Identify potential biomarkers and assays for diagnosis for rejection and graft injury
  2. Describe the integration of bioinformatics and datasets in transplantation
  3. Design a strategy to prospectively manage transplant patients using biomarkers to preserve organ function

Multi-drug-resistant Organisms

Thursday, November 17, 2016 - 3:00 pm EST

View Archive

Speaker: Stephanie Pouch, MD • The Ohio State University Medical Center
Moderator: Shirish Huprikar, MD • Icahn School of Medicine at Mount Sinai

Multidrug-resistant organisms (MDROs) pose a particular threat to solid organ transplant recipients.  Infections due to these pathogens are associated with significant morbidity and mortality, and current therapeutic options are limited.  

After participating in this webinar, the learner will be able to:

  1. Describe the epidemiology and outcomes of select MDRO infections in solid organ transplant recipients.
  2. Describe an approach to the use of organs from donors colonized or infected with CRE.
  3. Discuss the role of infection control and antimicrobial stewardship in curtailing the spread of MDROs in solid organ transplant recipients. 

Significance, Identification and Treatment of Post-thoracic Transplant Circulating Antibodies

Tuesday, November 15, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Jignesh Patel, MD • Cedars-Sinai Heart Institute
Moderator: Monica Colvin, MD, MS • University of Michigan

The presence of donor specific antibodies predisposes the thoracic allograft to the risk of antibody mediated rejection, chronic graft dysfunction and increased mortality. Optimal outcomes depend upon a comprehensive understanding of the significance of circulating antibodies after transplantation.  What are the best strategies for defining deleterious antibodies, what are the current available therapies to address these and how effective are they?
 

After participating in this webinar, the learner will be able to:
  1. Identify the significance of circulating antibodies in patients awaiting thoracic transplantation or in patients with development of de novo antibodies after transplantation.
  2. Order appropriate tests to detect relevant donor specific antibodies.
  3. Design rational therapies for the treatment of post-thoracic transplant circulating antibodies.

An Update on Current Concepts in Donor Specific Antibody Testing

Tuesday, October 18, 2016 - 2:00 pm to 3:00 pm EDT

VIEW ARCHIVE
 

Read the Q&A that wasn't answered during webinar

Speaker: Peter Nickerson, MD, FRCPC, FCAHS • University of Manitoba
Moderator: Leonardo Riella, MD, PhD • Harvard Medical School

After participating in this webinar, the learner will be able to:

  1. Understand the use and limitations of solid phase assays in identifying anti-HLA antibodies
  2. Describe the natural history and significance of DSA development post-transplant
  3. Discuss novel tools to improve specificity of solid phase assays 

Pediatric Re-transplantation: Who, When, and How to Ensure the Best Outcome

Tuesday, June 21, 2016 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Robert Ettenger, MD • UCLA Center for Health Science
Moderator: Vikas Dharnidharka, MD • Washington University

After participating in this webinar, the learner will be able to:

  1. Understand the measures that can be taken before, during and after the first transplant to promote the success of the second transplant
  2. Identify the appropriate immunological, psychological,and technical steps that should be taken to help assure an optimal outcome
  3. Describe the peri- and post-transplant care, including immunosuppression, that are necessary to obtain the best results

Strategies to Improve Recipient Readiness and Reduce Disparities

Tuesday, May 17, 2016 - 2:00 pm to 3:00 pm EDT

View Archive
 

Read the Q&A that wasn't answered during webinar

Speaker: Rachel Patzer, PhD • Emory Universtiy
Moderator:
Leo Riella, MD, PhD • Harvard Medical School

Significant barriers exist that may prevent patients from successfully navigating the complex transplant process to receive a transplant, including referral for transplant evaluation, starting the transplant evaluation, and completing the steps necessary to be placed on the national deceased donor waiting list or receive a kidney transplantation.  There are several strategies and tools that transplant center physicians and staff members can use to improve patient access to transplantation and reduce disparities.

After participating in this webinar, the learner will be able to:

  1. Understand the key patient- and health system-related barriers in access to multiple steps of the transplantation process
  2. Evaluate the existing evidence-base of approaches for improving patient readiness and access to transplantation
  3. Identify potential solutions that transplant centers can implement to reduce disparities in transplantation access

Kidney Allocation System Update: Where Are We So Far?

Tuesday, April 19, 2016 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Mark Aeder, MD • University Hospitals Case Medical Center
Moderator: Nicole Turgeon, MD •  Emory University

The Kidney Allocation System (KAS) was markedly revised on December 4, 2014, resulting in a major early alteration in national kidney distribution. Since a major objective was to provide equity in access to challenged candidates while not compromising vulnerable populations, and allowing for the bolus effects, this presentation will examine first year outcomes and assess the success in meeting the projected KAS goals.

After participating in this webinar, the learner will be able to:

  1. Identify the changes in kidney transplant distribution across recipient categories
  2. Distinguish the changes which will be maintained at a new level following the resolution of the initial bolus effect
  3. Begin to formulate potential modifications to KAS which would further achieve equity in allocation

Meeting Review: Cutting Edge of Transplantation: Solving the Organ Shortage

Tuesday, April 5, 2016 - 2:00 pm to 3:00 pm EDT

View Archive

Speaker: Richard Formica, MD • Yale University School of Medicine
Moderator: Anil Chandraker, MD, FRCP • Brigham & Women's Hospital

AST's Cutting Edge of Transplantation welcomed a record number of attendees to Phoenix February 25 - 27. During nearly 30 hours of sessions over three days, transplant professionals explored the history behind the organ shortage, what we are doing now to address the issues, and the direction we should take going forward. If you missed the meeting, this is your chance to understand the key highlights from CEOT. Dr. Formica will present the major takeaways, covering topics from allocation to organ utilization to policy to incentives/disincentives. This is a truly multidisciplinary webinar which will be useful to all transplant organ specialties. You may have missed CEOT but don't miss this highlights webinar.

What Makes for a Good Living Donor Program?

Tuesday, February 16, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Matt Cooper, MD • Medstar Georgetown Transplant Institute
Moderator: Harini Chakkera, MD • Mayo Clinic Hospital

After participating in this webinar, the learner will be able to:

  1. Define the components of a successful living donor kidney program to evaluate an efficient number of FTE’s and assistant personnel as well as developing and cultivating a culture within that personnel to best support living donors, their support staff, and their needs.
  2. Appraise the current resource allocation of their current living donor program and analyze where investments might be best undertaken to begin process improvements.
  3. Evaluate current living donor program metrics beyond number of potential donors and number of organs transplanted to work towards a more critical evaluation of measuring success in personnel activities as well as patient safety and program quality.

 

Management of Immunosuppression in the Setting of Acute Infectious Complications and Malignancy

Tuesday, January 26, 2016 - 2:00 pm to 3:00 pm EST

View Archive

Speaker: Daniel Brennan, MD • Washington University School of Medicine
Moderator: Robert Brown, MD • Weill Cornell Medical College

Optimal immunosuppression in organ transplantation is a balance between under immunosuppression, which is associated with graft rejection, and over immunosuppression, which is associated with infection and malignancy. Initial immunosuppression is designed to strike this balance. But how should one adjust immunosuppression when this balance is perturbed and there is an acute infectious complication or malignancy?

After participating in this webinar, the learner will be able to:

  1. Identify risks for development of acute infectious complications and malignancy in renal transplant recipients.
  2. Design rational immunosuppression strategies to manage acute infectious complications in renal transplant recipients.
  3. Design rational immunosuppression strategies to manage malignancy in renal transplant recipients.

Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights

Wednesday, May 20, 2015 (All day)

Kimberly Brown, MD • Henry Ford Hospital
Tiffany Kaiser, PharmD • University of Cincinnati
Moderated by Josh Levitsky, MD • Northwestern Memorial Hospital

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

This webinar is designed to focus on emerging therapies for HCV in transplant patients with specific attention to drug-drug interactions and limitations in patients with renal disease.

After participating in this webinar, the learner will be able to:

  1. Define current strategies for HCV treatment in the post transplant recipient
  2. Describe the limitations of current drug therapy in patients with renal disease
  3. Explain relevant drug-drug interactions of antiviral therapies with transplant medications

Cytomegalovirus: Prevention, Therapy, Immunity

Tuesday, April 21, 2015 - 1:00 pm EDT

Atul Humar, MD • University Health Network-University of Toronto
Camille Kotton, MDMassachusetts General Hospital
Raymund Razonable, MDMayo Clinic
Moderated by Shirish Huprikar, MD • Icahn School of Medicine at Mount Sinai

Archive

Read the Q&A that wasn't answered during webinar

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Dr. Kotton will describe the importance of prevention, and the various methods of preventing CMV, including; universal prophylaxis, preemptive therapy, and a hybrid approach, along with the merits and downfalls of each approach. Dr. Razonable will review the current recommendations for the treatment of cytomegalovirus infection and disease in transplant recipients, and discuss antiviral drugs in the pipeline that may be useful for the treatment of drug-resistant infections. Dr. Humar will explain how measurements of host immune response to CMV can be used to predict the risk of CMV reactivation in different settings, and how prevention and treatment strategies might be refined with the use of immune monitoring tools.

After participating in this webinar, the learner will be able to:

  1. Discuss the importance of CMV prevention, along with the various approaches used for optimal prevention
  2. Explain the standard treatment for CMV infection and disease in transplant recipients and discuss novel antiviral drugs
  3. Describe the potential for using immune monitoring tools to refine and improve prevention and treatment strategies

Monitoring the Alloresponse Before and After Transplantation

Tuesday, March 31, 2015 - 1:00 pm EDT

Peter Heeger, MD • Icahn School of Medicine at Mount Sinai
Moderated by Leonardo Riella, MD, PhD • Brigham and Women's Hospital

View Archive 

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The goal of this webinar is to describe the available data on pre- and post-transplant immune monitoring and how incorporating specific tests may help us diagnose, predict, and better treat our transplant recipients.

After participating in this webinar, the learner will be able to:

  1. Summarize the current most promising and best tested urine and peripheral blood, molecular, and cellular assays available for risk assessment following transplantation
  2. Detail the utility, pitfalls and limitations of currently available assays
  3. Propose future directions and trial designs required to develop and validate immune monitoring tools for clinical use

Hepatitis C Treatment in Non-liver Solid Organ Transplant Recipients

Tuesday, March 17, 2015 - 1:00 pm EDT

Norah Terrault MD, MPH • University of California, San Francisco
Moderated by Robert Brown, MD, MPH • Columbia University Medical Center

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The diagnosis of chronic hepatitis C has been considered a relative or absolute contraindication for non-liver transplantation in the past, due to concerns of liver disease progression post-transplantation and a lack of safe and effective therapies. The recent availability of interferon-free, all-oral, antiviral drug combinations to treat of chronic hepatitis C provides an opportunity to revise management algorithms to optimize the care of non-liver transplant candidates and recipients.

After participating in this webinar, the learner will be able to:

  1. Describe the components of the new HCV all-oral combinations, the role of ribavirin, and anticipated rates of HCV eradication with treatment
  2. Summarize the safety data of new HCV therapies as it pertains to non-liver transplant candidates and recipients, including key drug-drug interactions (HCV antivirals and immunosuppressive drugs)
  3. Evaluate the pros and cons of HCV treatment pre versus post-transplantation, including considerations related to use of anti-HCV positive donors

Medically Complex Living Donors: Candidacy, Care, and Informed Consent

Tuesday, February 17, 2015 - 2:00 pm EST

David Serur, MDNew York Presbyterian Weill Cornell
Elisa Gordon, PhD, MPHNorthwestern University
Catherine Garvey, RN, BA, CCTC • University of Minnesota Health

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The long-term acceptance of living donor transplantation has been based on a combination of excellent recipient outcomes and belief that in actuarial terms, there is no increased risk of living with one kidney. However, recent studies have raised controversy and concerns regarding the long-term risks of CKD in kidney donors. How do we interpret these findings? How do we evaluate and when do we clear donors with pre-existing medical conditions like hypertension, obesity, kidney stones, etc., and convey divergent opinions to patients? Comprehensive donor consent remains at the core of this process. Though perceived as challenging existing assumptions, the disclosure of new data will enable a better understanding of the risks so that potential living donors can make a more meaningful, informed decision.

After participating in this webinar, the learner will be able to:

  1. Distinguish between 'low risk donors' and medically complex living donors
  2. Evaluate the meanings of new studies regarding donor risk
  3. Refine the current informed consent process in light of the evolving data

Multiorgan Transplantation: One Organ Too Many?

Tuesday, February 10, 2015 - 2:00 pm EST

Peter Reese, MD, MSCE • University of Pennsylvania
John Friedewald, MDNorthwestern Medicine
Moderated by: Jason Wertheim, MD, PhD • Northwestern University

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The debate over the appropriateness of combined liver and kidney transplants was stoked by the introduction of the MELD system and continues today as the waiting list for kidney alone candidates continues to grow. This education session will feature a review of the current data and experience with combined liver and kidney transplantation and will explore the controversial topics of when to allocate a kidney to candidates with liver failure and acute kidney injury.

After participating in this webinar, the learner will be able to:

  1. Describe the current policies at UNOS regarding simultaneous liver-kidney allocation
  2. Explain data related to outcomes for liver transplant candidates with kidney injury
  3. Summarize arguments and ethics surrounding the development of new allocation policies for simultaneous liver-kidney transplantation

Treatment of Antibody-mediated Rejection in Thoracic Transplants

Tuesday, January 20, 2015 - 2:00 pm EST

Jon Kobashigawa, MD • Cedars-Sinai Heart Institute
Matt Morrell, MD • University of Pittsburgh School of Medicine
Moderated by Julie Yabu, MD • Stanford University

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Explore the diagnosis and treatment strategies, including the role of desensitization, in lung and heart transplantation. Discuss challenges and avenues for further research and investigation.

After participating in this webinar, the learner will be able to:

  1. Describe how to diagnose antibody-mediated rejection in lung and heart transplant recipients.
  2. Evaluate and review the desensitization strategies currently used in lung and heart transplant candidates and recipients.
  3. Summarize the different treatment approaches for treatment of antibody-mediated rejection.
     

Vaccine Updates in SOT: What's New, What's Standard of Care?

Tuesday, November 18, 2014 - 2:00 pm EST

Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center
Deepali Kumar, MD, MSc, FRCPC • University Health Network
Moderated by Camille Kotton, MD • Massachusetts General Hospital

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Transplant clinicians strive to prevent infection, and vaccination provides an opportunity to expand this effort. The current recommendations for vaccination, innovative research, and opportunity for advancing these efforts will be discussed.

After participating in this webinar, the learner will be able to:

  1. Explore current pre- and post-transplant vaccination recommendations for pediatric and adult transplant candidates/recipients.
  2. Appraise recent vaccination studies in transplantation with a focus on live-vaccines and more recently approved vaccinations.
  3. Identify new opportunities for vaccination in transplantation that are emerging.

Kidney Allocation System Changes: Strategies to Improve Recipient Readiness and Reduce Disparities

Tuesday, November 4, 2014 - 2:00 pm EST

Gena Boyle, MPA • UNOS
Richard Formica, MD • Yale University
Moderated by Nicole Turgeon, MD • Emory University

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

The new kidney allocation system is being implemented on December 4, 2014. Is your transplant program, OPO, and/or histocompatibility laboratory ready? During this webinar, the presenters will walk through the six major elements of the new kidney allocation system. For each element, the presenters will use screen shots and other illustrations to provide information on:

  • The essential preparations that transplant programs, histocompatibility laboratories, and OPOs need to take to prepare for implementation
  • How the UNOS computer system is currently programmed to assist transplant programs with preparing their list for December 4
  • How the new system will capture and use these new data elements
  • Helpful hints for complying with the new policy
  • Answers to frequently asked questions

After participating in this webinar, the learner will be able to:

  1. Describe the impact of upcoming policy and system changes related to the new kidney allocation system for patients and the transplant centers.
  2. Utilize tools and resources provided by the OPTN to prepare for system implementation for patients and the transplant centers.
  3. Identify methods for compliance with the new kidney allocation policies for transplant centers.

World Transplant Congress 2014: Clinical Highlights

Tuesday, October 21, 2014 - 1:00 pm EDT

Christian Oberkofler, MDUniversity Hospital Zurich
Thomas Mueller, MD, PhDUniversity Hospital Zurich

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.

After participating in this webinar, the learner will be able to:

  1. Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
  2. Discuss living donor safety in respect to current publications and concerns
  3. Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation

Role of HLA Testing in Pre- and Post-transplant Monitoring for SOT: What it Can and Cannot Tell Us

Wednesday, May 21, 2014 (All day)

Read Q&A that wasn't answered during the webinar

 View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Explore the relevance of HLA testing before and after transplant in solid organ transplantation. At the end of this webinar, participants will be able to:

  1. Understand the enhanced methods of HLA typing and antibody detection now available before transplant
  2. Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
  3. Appreciate the limitations of HLA testing and the importance of context in interpretation

A Discussion of Risk in Living Kidney Donors

Wednesday, April 23, 2014 (All day)

View Archive

Read Q&A that was not answered during the webinar

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:

  • A brief overview of risks of living kidney donation known to date
  • Discussion of the study design, methods and statistics in the manuscripts
  • Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information 

Links to manuscripts:

Hepatitis C Eradication: Liver Transplant Patients and Beyond

Wednesday, March 19, 2014 (All day)

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What you'll learn:

  1. Describe the common targets for direct acting antiviral therapy for HCV
  2. Understand current side effects and cure rates to therapy for HCV in liver transplant patients
  3. Discuss all oral DAA drug cocktails for HCV that can and will be used in the near future in transplant patients

Complying with New UNOS Living Donor Care Policies

Wednesday, February 19, 2014 (All day)

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What You'll Learn:

  1. Describe OPTN living donor policy requirements for the medical and psychosocial evaluation
  2. Describe OPTN policy requirements on living donor care, including requirements for follow-up, reporting, and the role of the independent living donor advocate (ILDA)
  3. Describe strategies to assist programs in monitoring compliance with living donor care requirements

Update on Kidney Allocation

Wednesday, January 22, 2014 (All day)

View Archive

Additional Q&A not covered during the webinar.

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What You'll Learn:

  1. An update on the newly approved kidney allocation policy
  2. How to address implementation within your own transplant program
  3. What will this mean for patients currently on the list and those being currently evaluated

Adherence Tools of Today and Tomorrow: Improving Adherence in the Challenging Transplant Patient

Wednesday, December 18, 2013 (All day)

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What You'll Learn:

  1. Identify risk factors for non-adherence and tools to measure non-adherence
  2. Evaluate the traditional methods used to improve/monitor medication adherence
  3. Review today's mobile adherence technologies for improving/monitoring medication adherence
  4. Summarize tomorrow's technologies for improving/monitoring medication adherence

International Pancreas and Islet Transplant Association World Congress: 2013 Summary (IPITA 2013)

Wednesday, November 20, 2013 (All day)

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Were you unable to attend the IPITA World Congress in September or need a review of talks you might have missed? If so, attend this webinar for a meeting review, and get caught up on all of the highlights you need to know!

Dr. Peter Stock, IPITA 2013 Congress Chair, will provide a meeting summary highlighting the marked improvements in rates of insulin independence following both pancreastic islet and whole organ pancreas transplants for diabetes mellitus, as well as novel strategies for increasing the source of beta cells (stem cells/xenotransplants) and blocking the immune response.

Updates on the International CMV Consensus Guidelines and the AST ID Guidelines Third Edition

Wednesday, October 23, 2013 (All day)

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What You'll Learn:

  1. Appreciate highlights of updated ID COP Guidelines published in 2013
  2. Appraise novel additions to ID COP Guidelines published in 2013
  3. Review Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

Click here to download additional questions that were answered offline by Dr. Camille Kotton. 

Banff Conference on Allograft Pathology: 2013 Summary

Wednesday, October 16, 2013 (All day)

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What You'll Learn:

  1. Summarize the major features of the 2013 Banff Conference on Allograft Pathology, held from August 19-23 in Comandatuba, Brazil
  2. Review the findings of the current Banff Working Groups that were presented at the conference
  3. Present the newly revised Banff Classification for antibody-mediated rejection in renal allografts, including the rationale for the revisions and the process involved in reaching a consensus on these
  4. Introduce the three new Banff Working Groups that have been formed as a result of presentations and discussions at the conference

Click here to download additional questions that were answered offline by Dr. Mark Haas. 

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.